Integrative epigenomic and highthroughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer

Enhancers are distal cis-regulatory elements required for cell-specific gene expression and cell fate determination. In cancer, enhancer variation has been proposed as a major cause of inter-patient heterogeneity— however, most predicted enhancer regions remain to be functionally tested.